FOS and breast neoplasm: However, expression of FOS, a pro-proliferative transcription factor, which has been validated in breast tumour samples and is highly expressed in relapse samples and treatment failures (Vendrell et al., 2008), was found to be downregulated at all time points (Fig. 4F).